secwatch / observer
8-K filed November 17, 2026, 4:30 PM ET ticker ALZN CIK 0001677077
regulatory confidence high sentiment negative materiality 0.62

Alzamend pauses AL001 bipolar trial after FDA rejects enrollment-criteria change; MGH terminates BD SOW

Alzamend Neuro, Inc.

Featured in Daily 8-K Digest
Selected #6 for 2026-11-17. Read digest

Alzamend Neuro, Inc. filing history →

Source: SEC EDGAR
accession 0001214659-26-014504
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.